|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | CURB-65, PSI, and APACHE Ⅱ to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS 显示文摘 | Richards G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 2 | CURB- 65, PSI, and APACHE 11 to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS显示文摘 | Richards G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 3 | CURB-65,PSI,and APACHE It to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PR0WESS显示文摘 | Richards G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 4 | Severe community-acquired pneumonia as a course of severe sepsis:data from the PROWESS study显示文摘 | Laterre PF Garber G Levy H | 2005 | Crit Care Med2005，33，： | 1 |
| 5 | Chronotherapy and the molecular clock:Clinical implications in oncology显示文摘 | Innominato PF Levi FA Bjarnason GA | | 0，，： | 1 |
| 6 | Chronotherapy andthe molecular clock:Clinical implications in oncology显示文摘 | Innominato PF Levi FA Bjarnason GA | 2010 | AdvDrug Deliv Rev2010，62，910： | 1 |
| 7 | CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS 显示文摘 | Richard G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 8 | Gastric versus duodenal feeding and gastric tonometric measurements显示文摘 | Levy B Perrigault PF Gawalkiewicz P | 1998 | Crit Care Med1998，26，12： | 1 |
| 9 | CURB-65,PSI,and APACHE II to assess mortality risk in pa tients with severe sepsis and community acquired pneumonia in PROWESS显示文摘 | Richards G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 10 | Severe community acquired pneumonia as a cause of severe sepsis: data from the PROWESS study显示文摘 | Laterre PF Garber G Levy H | 2005 | Crit Care Med2005，33，9： | 1 |
| 11 | Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan显示文摘 | McMurry LM McDermott PF Levy SB | 1999 | Antimicrob Agents Chemother1999，43，： | 1 |
| 12 | CURB-65, PSI, and APACHE I] to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS 显示文摘 | Richards G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 13 | CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS 显示文摘 | Richards G Levy H Latcrre PF | 2011 | Intensive Care Med2011，26，1： | 1 |
| 14 | Severe community -acquired pneumonia as a causeof severe sepsis: Data from the PROWESSstudy 显示文摘 | Laterre PF Garber G Levy H | 2005 | Crit Care Med2005，33，1： | 1 |
| 15 | Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile显示文摘 | Levy PF Smith BF | 1984 | Gastroenterology1984，87，2： | 1 |
| 16 | Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS)trial显示文摘 | Laterre PF Levy H Clermont G | | 0，，： | 1 |
| 17 | CURB -65, PSI, and A- PACHE H to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS 显示文摘 | Richards G Levy H Laterre PF | 2011 | J IntensiveCare Med2011，26，1： | 1 |
| 18 | Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction显示文摘 | Vasan RS Beiser A D Agostino RB Levy D Selhub J Jacques PF | 2003 | JAMA2003，289，： | 1 |
| 19 | CURB-65,PSI,and APACHEⅡto assess mortality risk in patients with severe sepsis and community acquired pneumonia in prowess显示文摘 | Richards G Levy H Laterre PF | 2011 | J Intensive Care Med2011，26，1： | 1 |
| 20 | Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study显示文摘 | Laterre PF Garber G Levy H | 2005 | Crit Care Med2005，33，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员